CRISPR transgene designed to result in an indel (small insertion or deletion mutation) in a target gene when combined with a source of Cas9. Constitutively expresses two sgRNAs, both of which target sequence within the coding region of GABA-B-R3, immediately downstream of the translation initiation site.